Answers are grounded in this paper and cite their sources.
Most household product-choice models are evaluated as if a prediction should be issued for every eligible purchase event. This working paper studies a different operational question: can pre-event purchase history identify which household × product events are predictable enough to answer at all? The task is deliberately narrow. Conditional on a household making a purchase within a fixed six-SKU choice set, the target is the SKU selected on that occasion; the study does not model purchase incidence or the composition of a full next basket. Three predictors were developed in a nine-product panel. A market-prior baseline (B0) achieved 37.28% accuracy, a household-history model (B1) 64.53%, and a behavior-fusion model (B2) 65.52% across 17,408 forward-test events. In a separate 26,659-event practical-complexity study, B2 exceeded B1 by 1.2604 percentage points, with positive household- and week-cluster bootstrap intervals, but remained below a predeclared 3.0-point material-gain threshold. The public system therefore retains B1 as the simple predictor. The study then freezes P1, a parameter-free pre-event household-stability score based on history maturity, choice concentration, entropy, switching, and recent concentration, together with three operating cutoffs. In a first new-product batch, the frozen rule achieved 39.16% coverage at 76.18% accuracy, 21.49% at 83.55%, and 11.50% at 88.14%. In a second untouched representative batch containing 40,474 events from 99 evaluable product groups, the corresponding results were 41.08%/77.17%, 22.00%/84.78%, and 11.01%/90.06%. A separate department challenge reached 79.33% accuracy at 40.22% coverage, versus 61.18% for B1 on all events. The evidence supports a simple selective-prediction architecture: use pre-event household stability to decide when to make a conditional SKU-choice prediction and ABSTAIN otherwise. The current evidence grade is CONFIRMED_WITHIN_PANEL_CROSS_PRODUCT; independent retailer replication remains the next test. The result also defines a staged research and application agenda: external replication first, followed by tests of purchase incidence, promotion and price response, decision value, and only then broader commercialization.
No takes yet. Share an insight, caveat, or question.
T.Y. Lin (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: